An investor in AmerisourceBergen Corp. is taking aim at the directors of the Pennsylvania-based drug wholesaler with a books-and-records suit in Delaware seeking to investigate potential wrongdoing associated with the opioid crisis.
The Chancery Court lawsuit, filed Thursday, said there was a “credible basis” to believe that AmerisourceBergen’s brass breached their fiduciary duties and helped to fuel an epidemic of addiction by failing to properly control distribution and report suspicious sales of the drugs.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]